Delivery Order SPE2DB25D9321-SPE2DB25FQWMN

This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4568564288 IPOL VIAL 5ML, a pharmaceutical product, with a firm fixed price of $21,802.00 and a completion date of June 17, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IPOL VIAL 5ML, a pharmaceutical product, with a total ceiling value of $32,926.80 and a performance period ending on June 10, 2025. The contract is not set aside and is a Firm Fixed Price type. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention...

This is a $2,561.64 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA). The contract is for the provision of IPOL VIAL 5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently procure a comprehensive range of...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a potential value of $10,673.50 and a completion date of January 30, 2024. This delivery order is part of a larger, single-award indefinite delivery...

This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4568604382 IPOL VIAL 5ML, with a ceiling value of $23,725.20 and a firm fixed price. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00, which...

This is a $8,567.19 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of IPOL VIAL 5ML, a pharmaceutical product, with a performance period through June 13, 2025. AmerisourceBergen Drug Corp is a for-profit corporation registered in the System for Award Management (SAM) and has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...

The Defense Logistics Agency Troop Support Medical awarded a $879.08 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561973228 ! IPOL VIAL 5ML. The prime contractor will deliver the requested pharmaceutical products to the place of performance in Conshohocken, Pennsylvania under a firm fixed price contract executed from August 29-30, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports Department of Defense...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566174748 IPOL VIAL 5ML, a pharmaceutical product, with a total ceiling value of $21,347.00. The contract is a firm fixed-price, indefinite delivery contract with an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4563407719 IPOL VIAL 5ML, with a potential value of $2,134.70 and a completion date of January 24, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides pharmaceutical products and services to...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of IPOL VIAL 5ML pharmaceuticals, with a firm fixed price of $23,908.64 and a completion date of January 17, 2024. The award was made on January 16, 2024, and there was no set-aside designation. Amerisourcebergen Drug Corp has a history of providing a...